{"transactions":[{"id":2381698,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":130134,"kind":"person","name":"Shah Jatin","position":1,"cik":"0001782186","reported_name":"Shah Jatin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-02-22T21:19:03.000Z","date":"2022-02-17","kind":"sale","acquired":false,"shares":1306,"price":12.1234,"value":15833.1604,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on February 17, 2022 on behalf of a group of employees of Karyopharm Therapeutics Inc. to satisfy the payment of withholding tax liability of such employees."}],"balance_after":129450,"source":{"system":"sec-edgar","filing":"0001209191-22-011650","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919122011650/doc4.xml","form_type":"4"}},{"id":2406011,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":130134,"kind":"person","name":"Shah Jatin","position":1,"cik":"0001782186","reported_name":"Shah Jatin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-02-09T22:27:50.000Z","date":"2022-02-07","kind":"sale","acquired":false,"shares":1704,"price":9.862,"value":16804.848,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on February 7, 2022 on behalf of a group of employees of Karyopharm Therapeutics Inc. to satisfy the payment of withholding tax liability of such employees."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 1,323 shares acquired under the Karyopharm Therapeutics Inc. 2013 Employee Stock Purchase Plan on October 31, 2021."}],"balance_after":130756,"source":{"system":"sec-edgar","filing":"0001209191-22-008130","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919122008130/doc4.xml","form_type":"4"}},{"id":2634696,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":130134,"kind":"person","name":"Shah Jatin","position":1,"cik":"0001782186","reported_name":"Shah Jatin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-07-13T22:21:51.000Z","date":"2021-07-12","kind":"tax_withholding","acquired":false,"shares":665,"price":9.73,"value":6470.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy the reporting person's tax obligation in connection with the vesting of 2,413 restricted stock units on July 11, 2021."}],"balance_after":131137,"source":{"system":"sec-edgar","filing":"0001209191-21-046589","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919121046589/doc4.xml","form_type":"4"}},{"id":2718213,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":130134,"kind":"person","name":"Shah Jatin","position":1,"cik":"0001782186","reported_name":"Shah Jatin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-05-11T12:58:27.000Z","date":"2021-05-07","kind":"purchase","acquired":true,"shares":23250,"price":8.6018,"value":199991.85,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $8.5850 to $8.61, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 861 shares acquired by the reporting person under the Karyopharm Therapeutics Inc. 2013 Employee Stock Purchase Plan on April 30, 2021."}],"balance_after":131802,"source":{"system":"sec-edgar","filing":"0001209191-21-031481","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919121031481/doc4.xml","form_type":"4"}},{"id":2825518,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":130134,"kind":"person","name":"Shah Jatin","position":1,"cik":"0001782186","reported_name":"Shah Jatin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-03-02T01:17:07.000Z","date":"2021-02-25","kind":"grant","acquired":true,"shares":59968,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on February 25, 2021 pursuant to the Plan.  The shares underlying this option vest as to 25% of the shares on February 25, 2022, with the remaining 75% vesting in 36 equal monthly installments thereafter."}],"balance_after":59968,"derivative":{"exercise_price":14.56,"expiration_date":"2031-02-24","underlying":"Common Stock","underlying_shares":59968},"source":{"system":"sec-edgar","filing":"0001209191-21-015487","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919121015487/doc4.xml","form_type":"4"}},{"id":2825517,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":130134,"kind":"person","name":"Shah Jatin","position":1,"cik":"0001782186","reported_name":"Shah Jatin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-03-02T01:17:07.000Z","date":"2021-02-25","kind":"grant","acquired":true,"shares":22013,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the award of restricted stock units (\"RSUs\") pursuant to the Karyopharm Therapeutics Inc. 2013 Stock Incentive Plan (the \"Plan\"). RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The RSUs vest in four equal annual installments beginning February 25, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reporting person has reported prior awards of RSUs in Table II of Form 4. The total reported in Column 5 includes the 22,013 newly awarded RSUs, 33,887 RSUs previously reported in Table II, and 51,791 shares of common stock."}],"balance_after":107691,"source":{"system":"sec-edgar","filing":"0001209191-21-015487","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919121015487/doc4.xml","form_type":"4"}},{"id":2842775,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":130134,"kind":"person","name":"Shah Jatin","position":1,"cik":"0001782186","reported_name":"Shah Jatin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-02-23T01:12:44.000Z","date":"2021-02-18","kind":"sale","acquired":false,"shares":1186,"price":14.8312,"value":17589.8032,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on February 18, 2021 on behalf of a group of employees of Karyopharm Therapeutics Inc. to satisfy the payment of withholding tax liability of such employees."}],"balance_after":51791,"source":{"system":"sec-edgar","filing":"0001209191-21-012968","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919121012968/doc4.xml","form_type":"4"}},{"id":2853598,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":130134,"kind":"person","name":"Shah Jatin","position":1,"cik":"0001782186","reported_name":"Shah Jatin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2021-02-17T23:48:42.000Z","date":"2021-02-15","kind":"exercise","acquired":false,"shares":4850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Restricted stock units convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 15, 2019, the reporting person was granted 19,400 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.  25% of the restricted stock units vested on February 15, 2021.  Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, but in any event within 30 days of such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 15, 2019, the reporting person was granted 19,400 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.  25% of the restricted stock units vested on February 15, 2021.  Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, but in any event within 30 days of such date."}],"balance_after":9700,"derivative":{"underlying":"Common Stock","underlying_shares":4850},"source":{"system":"sec-edgar","filing":"0001209191-21-011494","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919121011494/doc4.xml","form_type":"4"}},{"id":2853597,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":130134,"kind":"person","name":"Shah Jatin","position":1,"cik":"0001782186","reported_name":"Shah Jatin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-02-17T23:48:42.000Z","date":"2021-02-15","kind":"exercise","acquired":true,"shares":4850,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Restricted stock units convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis."}],"balance_after":52977,"source":{"system":"sec-edgar","filing":"0001209191-21-011494","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919121011494/doc4.xml","form_type":"4"}},{"id":2853596,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":130134,"kind":"person","name":"Shah Jatin","position":1,"cik":"0001782186","reported_name":"Shah Jatin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-02-17T23:48:42.000Z","date":"2021-02-11","kind":"sale","acquired":false,"shares":1748,"price":15.5191,"value":27127.3868,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on February 11, 2021 on behalf of a group of employees of Karyopharm Therapeutics Inc. to satisfy the payment of withholding tax liability of such employees."}],"balance_after":48127,"source":{"system":"sec-edgar","filing":"0001209191-21-011494","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919121011494/doc4.xml","form_type":"4"}},{"id":2871316,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":130134,"kind":"person","name":"Shah Jatin","position":1,"cik":"0001782186","reported_name":"Shah Jatin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2021-02-10T02:56:09.000Z","date":"2021-02-05","kind":"exercise","acquired":false,"shares":5650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 5, 2020, the reporting person was granted 22,600 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.  25% of the restricted stock units vested on February 5, 2021.  Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, but in any event within 30 days of such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 5, 2020, the reporting person was granted 22,600 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.  25% of the restricted stock units vested on February 5, 2021.  Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, but in any event within 30 days of such date."}],"balance_after":16950,"derivative":{"underlying":"Common Stock","underlying_shares":5650},"source":{"system":"sec-edgar","filing":"0001209191-21-009138","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919121009138/doc4.xml","form_type":"4"}},{"id":2871315,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":130134,"kind":"person","name":"Shah Jatin","position":1,"cik":"0001782186","reported_name":"Shah Jatin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2021-02-10T02:56:09.000Z","date":"2021-02-05","kind":"exercise","acquired":true,"shares":5650,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 996 shares acquired under the Karyopharm Therapeutics Inc. 2013 Employee Stock Purchase Plan on April 30, 2020."}],"balance_after":49875,"source":{"system":"sec-edgar","filing":"0001209191-21-009138","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919121009138/doc4.xml","form_type":"4"}},{"id":2992333,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":130134,"kind":"person","name":"Shah Jatin","position":1,"cik":"0001782186","reported_name":"Shah Jatin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2020-11-05T01:16:35.000Z","date":"2020-07-11","kind":"exercise","acquired":false,"shares":2413,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On July 11, 2019, the reporting person was granted 9,650 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.  25% of the restricted stock units vested on July 11, 2020.  Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, but in any event within 30 days of such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On July 11, 2019, the reporting person was granted 9,650 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.  25% of the restricted stock units vested on July 11, 2020.  Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, but in any event within 30 days of such date."}],"balance_after":7237,"derivative":{"underlying":"Common Stock","underlying_shares":2413},"source":{"system":"sec-edgar","filing":"0001209191-20-057052","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919120057052/doc4.xml","form_type":"4"}},{"id":2992332,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":130134,"kind":"person","name":"Shah Jatin","position":1,"cik":"0001782186","reported_name":"Shah Jatin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-11-05T01:16:35.000Z","date":"2020-07-15","kind":"sale","acquired":false,"shares":589,"price":19.46,"value":11461.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 646 shares acquired by the reporting person under the Karyopharm Therapeutics Inc. 2013 Employee Stock Purchase Plan on October 31, 2020."}],"balance_after":43229,"source":{"system":"sec-edgar","filing":"0001209191-20-057052","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919120057052/doc4.xml","form_type":"4"}},{"id":2992331,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":130134,"kind":"person","name":"Shah Jatin","position":1,"cik":"0001782186","reported_name":"Shah Jatin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-11-05T01:16:35.000Z","date":"2020-07-11","kind":"exercise","acquired":true,"shares":2413,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis."}],"balance_after":43172,"source":{"system":"sec-edgar","filing":"0001209191-20-057052","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919120057052/doc4.xml","form_type":"4"}},{"id":3255874,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":130134,"kind":"person","name":"Shah Jatin","position":1,"cik":"0001782186","reported_name":"Shah Jatin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-02-21T22:58:23.000Z","date":"2020-02-19","kind":"sale","acquired":false,"shares":1375,"price":16.4819,"value":22662.6125,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on February 19, 2020 on behalf of a group of employees of Karyopharm Therapeutics Inc. to satisfy the payment of withholding tax liability of such employees."}],"balance_after":40759,"source":{"system":"sec-edgar","filing":"0001209191-20-011697","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919120011697/doc4.xml","form_type":"4"}},{"id":3262238,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":130134,"kind":"person","name":"Shah Jatin","position":1,"cik":"0001782186","reported_name":"Shah Jatin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2020-02-19T23:16:39.000Z","date":"2020-02-15","kind":"exercise","acquired":false,"shares":4850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 15, 2019, the reporting person was granted 19,400 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. 25% of the restricted stock units vested on February 15, 2020. Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, but in any an event within 30 days of such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 15, 2019, the reporting person was granted 19,400 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. 25% of the restricted stock units vested on February 15, 2020. Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, but in any an event within 30 days of such date."}],"balance_after":14550,"derivative":{"underlying":"Common Stock","underlying_shares":4850},"source":{"system":"sec-edgar","filing":"0001209191-20-010762","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919120010762/doc4.xml","form_type":"4"}},{"id":3262237,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":130134,"kind":"person","name":"Shah Jatin","position":1,"cik":"0001782186","reported_name":"Shah Jatin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2020-02-19T23:16:39.000Z","date":"2020-02-15","kind":"exercise","acquired":true,"shares":4850,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,659 shares acquired under the Karyopharm Therapeutics Inc. 2013 Employee Stock Purchase Plan."}],"balance_after":42134,"source":{"system":"sec-edgar","filing":"0001209191-20-010762","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919120010762/doc4.xml","form_type":"4"}},{"id":3284080,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":130134,"kind":"person","name":"Shah Jatin","position":1,"cik":"0001782186","reported_name":"Shah Jatin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2020-02-07T21:20:46.000Z","date":"2020-02-05","kind":"grant","acquired":true,"shares":22600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Karyopharm Therapeutics Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning February 5, 2021, the first anniversary of the grant date. Vested shares will be delivered to the reporting person as soon as practicable following each vesting date, but in any event within 30 days of such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning February 5, 2021, the first anniversary of the grant date. Vested shares will be delivered to the reporting person as soon as practicable following each vesting date, but in any event within 30 days of such date."}],"balance_after":22600,"derivative":{"underlying":"Common Stock","underlying_shares":22600},"source":{"system":"sec-edgar","filing":"0001209191-20-007514","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919120007514/doc4.xml","form_type":"4"}},{"id":3284079,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":130134,"kind":"person","name":"Shah Jatin","position":1,"cik":"0001782186","reported_name":"Shah Jatin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-07T21:20:46.000Z","date":"2020-02-05","kind":"grant","acquired":true,"shares":60600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 5, 2020.  The shares underlying this option vest as to 25% of the shares on February 5, 2021, with the remaining 75% vesting in 36 equal monthly installments thereafter."}],"balance_after":60600,"derivative":{"exercise_price":18,"expiration_date":"2030-02-04","underlying":"Common Stock","underlying_shares":60600},"source":{"system":"sec-edgar","filing":"0001209191-20-007514","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919120007514/doc4.xml","form_type":"4"}},{"id":3461757,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":130134,"kind":"person","name":"Shah Jatin","position":1,"cik":"0001782186","reported_name":"Shah Jatin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2019-07-15T20:05:21.000Z","date":"2019-07-11","kind":"grant","acquired":true,"shares":9650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Karyopharm Therapeutics Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning July 11, 2020, the first anniversary of the grant date.  Vested shares will be delivered to the reporting person as soon as possible following each vesting date, but in any event within 30 days of such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning July 11, 2020, the first anniversary of the grant date.  Vested shares will be delivered to the reporting person as soon as possible following each vesting date, but in any event within 30 days of such date."}],"balance_after":9650,"derivative":{"underlying":"Common Stock","underlying_shares":9650},"source":{"system":"sec-edgar","filing":"0001209191-19-042055","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919119042055/doc4.xml","form_type":"4"}},{"id":3461756,"issuer":{"id":781,"kind":"organization","name":"Karyopharm Therapeutics Inc.","symbol":"KPTI"},"owners":[{"id":130134,"kind":"person","name":"Shah Jatin","position":1,"cik":"0001782186","reported_name":"Shah Jatin","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-07-15T20:05:21.000Z","date":"2019-07-11","kind":"grant","acquired":true,"shares":25700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on July 11, 2019.  The shares underlying this option vest as to 25% of the shares on July 11, 2020, with the remaining 75% vesting in 36 equal monthly installments thereafter."}],"balance_after":25700,"derivative":{"exercise_price":7.61,"expiration_date":"2029-07-10","underlying":"Common Stock","underlying_shares":25700},"source":{"system":"sec-edgar","filing":"0001209191-19-042055","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1503802/000120919119042055/doc4.xml","form_type":"4"}}]}